tiprankstipranks
GlucoTrack (GCTK)
NASDAQ:GCTK
US Market

GlucoTrack (GCTK) Stock Price & Analysis

25 Followers

GCTK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.13 - $0.99
Previous Close$0.56
Volume70.45K
Average Volume (3M)212.42K
Market Cap
$15.06M
Enterprise Value$8.18M
Total Cash (Recent Filing)$6.89M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.6
Beta-0.89
May 15, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.35
Shares Outstanding26,756,369
10 Day Avg. Volume227,788
30 Day Avg. Volume212,423
Standard Deviation0.24
R-Squared0.00608
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)2.79
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

11.03%0.00%0.08%88.89%
11.03% Insiders
0.08% Other Institutional Investors
88.89% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

GCTK FAQ

What was GlucoTrack’s price range in the past 12 months?
GlucoTrack lowest stock price was $0.13 and its highest was $0.99 in the past 12 months.
    What is GlucoTrack’s market cap?
    Currently, no data Available
    When is GlucoTrack’s upcoming earnings report date?
    GlucoTrack’s upcoming earnings report date is May 15, 2018 which is 2188 days ago.
      How were GlucoTrack’s earnings last quarter?
      Currently, no data Available
      Is GlucoTrack overvalued?
      According to Wall Street analysts GlucoTrack’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does GlucoTrack pay dividends?
        GlucoTrack does not currently pay dividends.
        What is GlucoTrack’s EPS estimate?
        GlucoTrack’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does GlucoTrack have?
        GlucoTrack has 26,756,369 shares outstanding.
          What happened to GlucoTrack’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of GlucoTrack?
          Currently, no hedge funds are holding shares in GCTK
          ---

          GlucoTrack Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          GlucoTrack

          Integrity Applications, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Ashkelon, Israel.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          GoodRx Holdings
          Dexcom
          Tandem Diabetes Care
          Insulet
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis